Haemodynamic effects of amlodipine in elderly patients with arterial hypertension

Clinical Drug Investigation

Volumn 13, Issue SUPPL. 1, 1997, Pages 12-16

  Gambini, Claudio ^a   Antonicelli, Roberto ^a   Gesuita, Rosaria ^a   Paciaroni, Enrico ^a  

^a INRCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT;

AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; ASTHENIA; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; DRUG TOLERABILITY; EDEMA; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE SIZE; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE;

EID: 0030744080     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199700131-00004     Document Type: Article

References (21)

1. Burges RA, Dodd MG, Gardiner DG. Pharmacologic profile of amlodipine. Am J Cardiol 1989; 64 (17): 10-8
2. Murdoch D, Heel RC. Amlodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 1991; 41: 478-505
3. Abernethy DR. The pharmacokinetic profile of amlodipine. Am Heart J 1989; 118 (5 Pt 2): 1100-3
4. Carter AJ, Gardiner DG, Burges RA. Natriuretic activity of amlodipine, diltiazem and nitrendipine in saline-loaded anesthetized dogs. J Cardiovasc Pharmacol 1988; 12 Suppl. 7: S34-8
5. Fleckenstein A, Frey M, Zorn J, et al. Particular antihypertensive profile of amlodipine administered orally to Okamoto rats (SHRs) and NaCl-loaded salt-sensitive Dahl rats. J Cardiovasc Pharmacol 1988; 12 Suppl. 7: S39-40
6. Stopher DA, Beresford AP, Macrae PV, et al. The metabolism and pharmacokinetics of amlodipine in humans and animals. J Cardiovasc Pharmacol 1988; 12 Suppl. 7: S55-59
7. Abernethy DR, Gutkowska J, Winterbottom LM. Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition. Clin Pharmacol Ther 1990; 48 (1): 76-86
8. Elliot HL, Green ST, Vincent J, et al. An assessment of the pharmacokinetics and pharmacodynamics of single doses of amlodipine in elderly normotensives. Pharmacol Res 1992; 26 (1): 33-9
9. Abernethy DR, Gutkowska J, Lambert DM. Amlodipine in elderly hypertensive patients: pharmacokinetics and pharmacodynamics. J Cardiovasc Pharmacol 1988; 12 Suppl. 7: S67-71
10. Webster J, Robb OJ, Jeffers TA, et al. Once-daily amlodipine in the treatment of mild to moderate hypertension. J Cardiovasc Pharmacol 1988; 12 Suppl. 7: S72-5
11. Osterloh I. The safety of amlodipine. Am Heart J 1989; 118 (5 Pt 2): 1114-9
12. Grandinetti O, Feraco E. Middle term evaluation of amlodipine vs nitrendipine: efficacy, safety and metabolic effects in elderly hypertensive patients. Clin Exp Hypertens 1993; 15 Suppl. 1: 197-210
13. Fisher M, Grotts J. New uses for calcium channel blockers: therapeutic implications. Drugs 1993; 46 (6): 961-75
14. La Civita L, Pitaro M, et al. Amlodipine in the treatment of Raynaud's phenomenom. Br J Rheumatol 1993; 32 (6): 524-5
15. Reams GP, Lav A, et al. Amlodipine therapy corrects renal abnormalities encountered in the hypertensive state. Am J Kidney Dis 1987; 10 (6): 446-51
16. Abernethy DR. An overview of the pharmacokinetics and pharmacodynamics of amlodipine in elderly persons with systemic hypertension. Am J Cardiol 1994; 73 (3): 10A-17A
17. Kirkendall WM, Feinleib M, Freis ED, et al. Recommendations for human blood pressure determination by sphygmomanometers. Hypertension 1981; 3 (4): 510A-19A
18. Birkenhauer WH, Reid JL, editors. Handbook of hypertension - aging and circulatory control in normotensive and hypertensive states. Vol 12. New York: Elsevier, 1989: 1-143
19. Levi RI, Brensike JF, Epstein SE, et al. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery diseases: results of the NHLBI type II Coronary Intervention Study. Circulation 1984; 69: 325-37
20. Sharp SD, Williams RR, Hunt SC, et al. Coronary risk factors and the severity of angiographic coronary artery disease in members of high-risk pedigrees. Am Heart J 1992; 123 (2): 275-85
21. Wilson PW, Anderson KM, Castelli WP. Twelve year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham Offspring Study. Am J Med 1992; 90 (1): 11-6